These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 1474284)
41. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients. Rafi A; Donoghue HD; Stanford JL Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of polymerase chain reaction-based detection of Mycobacterium leprae for the diagnosis of leprosy. Bang PD; Suzuki K; Phuong le T; Chu TM; Ishii N; Khang TH J Dermatol; 2009 May; 36(5):269-76. PubMed ID: 19382997 [TBL] [Abstract][Full Text] [Related]
43. Screening of drugs for activity against Mycobacterium leprae. Baohong J; Matsuo Y; Colston MJ Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576 [No Abstract] [Full Text] [Related]
44. [Histopathology of leprosy]. Pinquier L; Ann Dermatol Venereol; 2011 Nov; 138(11):777-81. PubMed ID: 22078042 [No Abstract] [Full Text] [Related]
45. LightCycler real-time PCR for rapid detection and quantitation of Mycobacterium leprae in skin specimens. Rudeeaneksin J; Srisungngam S; Sawanpanyalert P; Sittiwakin T; Likanonsakul S; Pasadorn S; Palittapongarnpim P; Brennan PJ; Phetsuksiri B FEMS Immunol Med Microbiol; 2008 Nov; 54(2):263-70. PubMed ID: 18783434 [TBL] [Abstract][Full Text] [Related]
46. [Anti-leprosy vaccines and drugs]. Abe M Nihon Rai Gakkai Zasshi; 1994 Mar; 63(1):1-2. PubMed ID: 7928797 [No Abstract] [Full Text] [Related]
47. DNA amplification for detection of leprosy and assessment of efficacy of leprosy chemotherapy. Kampirapap K; Singtham N; Klatser PR; Wiriyawipart S Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):16-21. PubMed ID: 9614835 [TBL] [Abstract][Full Text] [Related]
48. Skin smears and the bacterial index (B) in multiple drug therapy leprosy control programs: an unsatisfactory and potentially hazardous state of affairs. Georgiev GD; McDougall AC Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):101-4. PubMed ID: 3286795 [No Abstract] [Full Text] [Related]
49. The chemotherapy of leprosy. Part 2. Ellard GA Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319 [No Abstract] [Full Text] [Related]
50. Report of 2 indigenous cases of leprosy from a European country: use of polymerase chain reaction-restriction fragment length polymorphism analysis of hsp65 gene for identification of Mycobacterium leprae directly from a clinical sample. Neonakis IK; Gitti Z; Kontos F; Baritaki S; Zerva L; Krambovitis E; Spandidos DA Diagn Microbiol Infect Dis; 2009 Jul; 64(3):331-3. PubMed ID: 19376672 [TBL] [Abstract][Full Text] [Related]
51. [Eradication of leprosy and public health. Vaccination and multidrug therapy]. Janaszek W Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583 [TBL] [Abstract][Full Text] [Related]
52. Single dose multidrug therapy for single lesion paucibacillry leprosy. Salafia A Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861 [No Abstract] [Full Text] [Related]
53. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment]. Ferracci C; Baquillon G; Pattyn SR Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799 [TBL] [Abstract][Full Text] [Related]
54. The debate over leprosy elimination versus sustainability of leprosy services. Indian J Lepr; 2005; 77(4):299-304. PubMed ID: 16465825 [No Abstract] [Full Text] [Related]
55. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335 [TBL] [Abstract][Full Text] [Related]
56. Prospects for chemotherapy of leprosy. Ji B Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659 [No Abstract] [Full Text] [Related]
57. [A role of polymerase chain reaction in the diagnosis of leprosy]. Saroiants LV Probl Tuberk Bolezn Legk; 2005; (7):44-7. PubMed ID: 16130429 [No Abstract] [Full Text] [Related]
58. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy. Levy L Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574 [No Abstract] [Full Text] [Related]
59. The normal mouse in experimental chemotherapy. Levy L Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):843-6. PubMed ID: 3325577 [No Abstract] [Full Text] [Related]
60. A Thai patient with generalised inflammatory skin disease 18 years after migration to Europe. Schmiedel S; Ehrhardt S; Moll I; Burchard GD Lancet; 2006 Apr; 367(9520):1458. PubMed ID: 16650656 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]